CORETESTS, INC.   
WEN LI   
REGULATORY AFFAIRS SPECIALIST 6190 YARROW DRIVE   
CARLSBAD CA 92011

Re: K150063 Trade/Device Name: ACCU NEWS One Step hCG Pregnancy Test Strip ACCU NEWS One Step hCG Pregnancy Test Cassette ACCU NEWS One Step hCG Pregnancy Test Midstream Regulation Number: 21 CFR 862.1155 Regulation Name: Human chorionic gonadotropin (HCG) test system Regulatory Class: II Product Code: LCX Dated: August 14, 2015 Received: August 17, 2015

Dear Wen Li:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA’s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act’s requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the

electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000- 1050.

If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH’s Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Katherine Serrano -S

Courtney H. Lias, Ph.D. For: Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

510(k) Number (if known) K150063

Device Name ACCU NEWS One Step hCG Pregnancy Test Strip ACCU NEWS One Step hCG Pregnancy Test Cassette ACCU NEWS One Step hCG Pregnancy Test Midstream

Indications for Use (Describe)

ACCU NEWS One Step Pregnancy Test Strip: The ACCU NEWS One Step Pregnancy Test Strip is a lateral flow immunoassay to qualitatively detect the presence of human Chorionic Gonadotropin (hCG) hormone in urine specimen to aid early detection of pregnancy for both prescription use and OTC use.

ACCU NEWS One Step Pregnancy Test Cassette: The ACCU NEWS One Step Pregnancy Test Cassette is a lateral flow immunoassay to qualitatively detect the presence of human Chorionic Gonadotropin (hCG) hormone in urine specimen to aid early detection of pregnancy for both prescription use and OTC use.

ACCU NEWS One Step Pregnancy Test Midstream: The ACCU NEWS One Step Pregnancy Test Midstream is a lateral flow immunoassay to qualitatively detect the presence of human Chorionic Gonadotropin (hCG) hormone in urine specimen to aid early detection of pregnancy for both prescription use and OTC use.

# CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

# \*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

“An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.”

# 510k Summary

A. Submitter Information Coretests Inc. 6190 Yarrow Drive, Carlsbad, CA 92011, USA. Phone Number: 858-333-1122 Contact Person: Wen Li Summary Prepared on September 29th, 2015

B. Trade Name, common name, classification name Trade Names: ACCU NEWSTM One Step hCG Pregnancy Test Strip, ACCU NEWSTM One Step hCG Pregnancy Test Cassette, and ACCU NEWSTM One Step hCG Pregnancy Test Midstream. Common Name: Qualitative Lateral Flow Immunoassay Classification: Class II Regulation Number: 21 CFR 862.1155 Human chorionic gonadotropin test system Product code: LCX Panel: Clinical Chemistry (75)

C. Predicate device K043443 Wondfo One Step HCG Urine Pregnancy Test

# D. Device description

ACCU NEWSTM One Step hCG Pregnancy Test is a qualitative lateral flow test for the detection of hCG (human chorionic gonadotropin) hormone, which is present in urine during the early stage of pregnancy. It is built on a basic lateral flow immunoassay test strip model containing 6 components as illustrated below:

![](images/0ab666d7a827fe1d1cda6af3d4eefd7468d983288dac717dc07239b6df3d638d.jpg)

The nitrocellulose membrane is coated with Goat anti-mouse IgG polyclonal antibody on the control line and anti-alpha hCG mouse monoclonal antibody on the test line. The conjugate pad contains colloidal-gold-labeled anti-beta mouse monoclonal hCG antibody. When urine specimen is drawn through the sample pad, the hCG present in the urine will react with the anti-beta monoclonal hCG antibody on the conjugate pad and the antialpha monoclonal hCG antibody on the test line to develop visible lines in the test region.

Test Result Interpretation:

Not Pregnant: No visible pink line appearing in the test region.   
Pregnant: A visible pink line appearing in the test region.   
Invalid: No visible line in control region, regardless if there is a visible line in the test region or not.

The ACCU NEWSTM One Step hCG Pregnancy Test is available in three different formats: 1) strip, 2) cassette, and 3) midstream.

# Strip Format

The Strip format is a test strip used by itself without any housing components. Urine specimen is collected in a cup and the sample pad is dipped into the urine directly.

# Cassette Format

The Cassette format includes a test strip housed in a plastic cassette. Urine specimen is collected in a cup and a dropper is provided to transfer the urine specimen to the sample well of the cassette, wetting the sample pad to activate the test.

# Midstream Format

The Midstream format includes a test strip housed in a plastic case with an absorbent tip contacting the sample pad of the test strip. When the absorbent tip is placed in a urine steam it draws urine specimen onto the sample pad of the test strip to activate the test.

All three formats are built on the basic test strip model containing 6 components as illustrated above. The strips used in the three different formats contains the same components except that the plastic adhesive backing card, absorbent pad and sample pad are in different sizes. This is specified in the table below:

<table><tr><td rowspan=1 colspan=1>Component</td><td rowspan=1 colspan=1>Strip</td><td rowspan=1 colspan=1>Cassette</td><td rowspan=1 colspan=1>Midstream</td></tr><tr><td rowspan=1 colspan=1>Plastic Adhesive Backing Card</td><td rowspan=1 colspan=1>300 x 80 mm</td><td rowspan=1 colspan=1>300 x 60 mm</td><td rowspan=1 colspan=1>300 x 85 mm</td></tr><tr><td rowspan=1 colspan=1>Absorbent pad</td><td rowspan=1 colspan=1>298×33 mm</td><td rowspan=1 colspan=1>298×23 mm</td><td rowspan=1 colspan=1>298×31mm</td></tr><tr><td rowspan=1 colspan=1>Sample Pad</td><td rowspan=1 colspan=1>300 x 24 mm</td><td rowspan=1 colspan=1>300 x 20 mm</td><td rowspan=1 colspan=1>300 x 40 mm</td></tr></table>

# E. Intended use

ACCU NEWSTM One Step Pregnancy Test Strip: The ACCU NEWSTM One Step Pregnancy Test Strip is a lateral flow immunoassay to qualitatively detect the presence of human Chorionic Gonadotropin (hCG) hormone in urine specimen to aid early detection of pregnancy for both prescription use and OTC use.

ACCU NEWSTM One Step Pregnancy Test Cassette: The ACCU NEWSTM One Step Pregnancy Test Cassette is a lateral flow immunoassay to qualitatively detect the presence of human Chorionic Gonadotropin (hCG) hormone in urine specimen to aid early detection of pregnancy for both prescription use and OTC use.

ACCU NEWSTM One Step Pregnancy Test Midstream: The ACCU NEWSTM One Step

Pregnancy Test Midstream is a lateral flow immunoassay to qualitatively detect the presence of human Chorionic Gonadotropin (hCG) hormone in urine specimen to aid early detection of pregnancy for both prescription use and OTC use.

F. Summary of the technological characteristics of your device compared to the predicate device   

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Subject Device</td><td rowspan=1 colspan=1>Predicate Device</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>It is intended for bothprofessional and over-the-counter use for qualitativedetection of hCG hormone inurine to aid early detection ofpregnancy.</td><td rowspan=1 colspan=1>It is intended for bothprofessional and over-the-counter use for qualitativedetection of hCG hormone inurine to aid early detection ofpregnancy.</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Urine</td><td rowspan=1 colspan=1>Urine</td></tr><tr><td rowspan=1 colspan=1>Technology</td><td rowspan=1 colspan=1>Lateral Flow Immunoassay</td><td rowspan=1 colspan=1>Lateral Flow Immunoassay</td></tr><tr><td rowspan=1 colspan=1>Basic Components</td><td rowspan=1 colspan=1>Test strip containingnitrocellulose membrane,sample pad, alpha and betahCG antibodies</td><td rowspan=1 colspan=1>Test strip containingnitrocellulose membrane,sample pad, alpha and beta hCGantibodies</td></tr><tr><td rowspan=1 colspan=1>Detection Limit</td><td rowspan=1 colspan=1>25 mIU/mL</td><td rowspan=1 colspan=1>25 mIU/mL</td></tr><tr><td rowspan=1 colspan=1>Storage Temperature</td><td rowspan=1 colspan=1>4-30°C</td><td rowspan=1 colspan=1>4-30°C</td></tr><tr><td rowspan=1 colspan=1>Formats</td><td rowspan=1 colspan=1>Strip, Cassette, Midstream</td><td rowspan=1 colspan=1>Strip, Cassette, Midstream</td></tr><tr><td rowspan=1 colspan=1>Traceability</td><td rowspan=1 colspan=1>WHO 3rd InternationalStandard</td><td rowspan=1 colspan=1>WHO 3rd International Standard</td></tr><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Feature</td><td rowspan=1 colspan=1>Subject Device</td><td rowspan=1 colspan=1>Predicate Device</td></tr><tr><td rowspan=1 colspan=1>Read Time</td><td rowspan=1 colspan=1>at 5 minutes</td><td rowspan=1 colspan=1>3-5 minutes</td></tr><tr><td rowspan=1 colspan=1>High Dosage HookEffect</td><td rowspan=1 colspan=1>No high dosage hook effectfor hCG up to 500,000mIU/mL</td><td rowspan=1 colspan=1>No high dosage hook effect forhCG up to 100,000 mIU/mL</td></tr><tr><td rowspan=1 colspan=1>Specificity</td><td rowspan=1 colspan=1>LH at 1000mIU/mL, FSH at1000mIU/mL, and TSH at1000μIU/mL</td><td rowspan=1 colspan=1>LH at 300mIU/mL, FSH at 300mIU/mL, and TSH at 1000mIU/mL</td></tr><tr><td rowspan=1 colspan=1>pH Interference</td><td rowspan=1 colspan=1>No interference for urine withpH 2-9</td><td rowspan=1 colspan=1>No interference for urine withpH 4-9</td></tr><tr><td rowspan=1 colspan=1>Specific GravityInterference</td><td rowspan=1 colspan=1>No interference for urine withSpecific Gravity 1.003-1.030</td><td rowspan=1 colspan=1>No interference for urine withSpecific Gravity 1.000-1.050</td></tr></table>

# G. Non-clinical performance data

# a. Read Time Window

To determine the optimal time to interpret the test results of the ACCU NEWSTM One Step hCG Pregnancy Test, 10 devices from each format (Strip, Cassette, and Midstream) were tested with each of the urine samples containing 0, 12.5, 18.75, 25, 50, and 100mIU/mL hCG. Data indicated that test result was most accurate when it

was interpreted at 5 minutes.

# b. Precision/Sensitivity

1. Three lots of devices for each format were used to test blind-labelled urine samples containing 0, 12.5, 18.75, 25, 50, and $1 0 0 \mathrm { m I U / m L }$ of hCG. All urine samples were calibrated against the hCG standard WHO $3 ^ { \mathrm { r d } }$ IS. The study was carried out at three sites (one internal site and two external sites representative of the intended use setting). Each site tested a unique lot of test device. For each format, at least 30 urine samples were tested for each concentration.

Table 1: Precision Study Data for Strip   

<table><tr><td rowspan=2 colspan=1>hCG conc. (mIU/mL)</td><td rowspan=1 colspan=2>Lot #1</td><td rowspan=1 colspan=2>Lot #2</td><td rowspan=1 colspan=2>Lot #3</td><td rowspan=1 colspan=2>Total</td></tr><tr><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>18.75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr></table>

Table 2: Precision Study Data for Cassette   

<table><tr><td rowspan=2 colspan=1>hCG conc. (mIU/mL)</td><td rowspan=1 colspan=2>Lot #1</td><td rowspan=1 colspan=2>Lot #2</td><td rowspan=1 colspan=2>Lot #3</td><td rowspan=1 colspan=2>Total</td></tr><tr><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>18.75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr></table>

Table 3: Precision Study Data for Midstream   

<table><tr><td rowspan=2 colspan=1>hCG conc. (mIU/mL)</td><td rowspan=1 colspan=2>Lot #1</td><td rowspan=1 colspan=2>Lot #2</td><td rowspan=1 colspan=2>Lot #3</td><td rowspan=1 colspan=2>Total</td></tr><tr><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>18.75</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td></tr><tr><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>59</td><td rowspan=1 colspan=1>1</td></tr><tr><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>0</td></tr></table>

Test result demonstrated that all three formats of ACCU NEWSTM One Step hCG Pregnancy Test were able to produce consistent and precise test results.

2. Linearity/Assay reportable range: Not applicable. This is a qualitative test.

3. Detection Limit:

The Precision/Sensitivity study demonstrated that the detection limit for the test was $2 5 \mathrm { m I U / m L }$ .

c. Traceability, Stability, Expected values (controls, calibrators, or methods)

The test is calibrated against reference material traceable to WHO International Standard 3rd edition.

A shelf-life stability test of the device was performed in accelerated temperature at $6 0 \mathrm { { ^ \circ C } }$ . The results support that the device was stable for 2 years when stored at 4- $3 0 \mathrm { { ^ \circ C } }$ .

# d. Comparison Study

Urine samples were randomly collected from 250 female donors from three sites at various times throughout the day. About $50 \%$ of the donors were suspected to be pregnant. Donor age range was from 18 to 43. Healthcare professionals tested each urine sample with each format of ACCU NEWSTM One Step hCG Pregnancy Test and a predicate hCG test. Test results were compared.

Table 4: Data Summary for Comparison Study   

<table><tr><td rowspan=3 colspan=2></td><td rowspan=1 colspan=6>ACCU NEWSTM One Step hCG Pregnancy Test</td></tr><tr><td rowspan=1 colspan=2>Midstream</td><td rowspan=1 colspan=2>Cassette</td><td rowspan=1 colspan=2>Strips</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=4 colspan=1>PredicateDeviceResult</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>% Agreement</td><td rowspan=1 colspan=2>100%</td><td rowspan=1 colspan=2>100%</td><td rowspan=1 colspan=2>100%</td></tr></table>

Test result demonstrated that test results from all three formats of the ACCU NEWSTM One Step hCG Pregnancy Test had $100 \%$ agreement with that of the predicate device.

# e. Specificity

Specificity was determined by testing the ACCU NEWSTM One Step hCG Test with structurally related compounds spiked in negative urine samples and positive (hCG $2 5 \mathrm { m I U / m L }$ ) urine samples. The compounds analyzed were luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid stimulating hormone (TSH). Five tests were performed for each compound. Result demonstrated that ACCU NEWSTM One Step hCG Test was not interfered by FSH, TSH, and LH at the levels of $1 0 0 0 \mathrm { m I U / m L }$ , $1 0 0 0 \mu \mathrm { I U / m L }$ , and $1 0 0 0 \mathrm { m I U / m L }$ respectively. However, LH, FSH, and TSH may cause false negative readings at concentrations of ${ > } 1 0 0 0 \ \mathrm { m I U / m L }$ , ${ > } 1 0 0 0 \ \mathrm { m I U / m L }$ , and ${ > } 1 0 0 0 ~ \mu \mathrm { I U / m L }$ respectively.

# f. Interference

# 1. Exogenous Compounds

To determine if some exogenous compounds would react and interfere with the ACCU NEWSTM One Step hCG Pregnancy Test, positive urine samples (hCG 25 $\mathrm { m U / m L }$ ) and negative urine samples were spiked with individual chemicals to specific concentrations. Each spiked urine sample was tested with five ACCU NEWSTM One Step hCG Pregnancy Test devices from each format. Results showed that ACCU NEWSTM One Step hCG Pregnancy Test was not interfered by the substances listed below at their specific concentrations.

<table><tr><td rowspan=1 colspan=1>Substance</td><td rowspan=1 colspan=1>Concentration</td></tr><tr><td rowspan=1 colspan=1>(1R,2S)-(-)-Ephedrine</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>(1S,2R)-(+)-Ephedrine</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylate Acid</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Albumin (Human)</td><td rowspan=1 colspan=1>2000 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Ampicillin</td><td rowspan=1 colspan=1>5.3 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>2 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Cannabinol</td><td rowspan=1 colspan=1>10 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Gentisic Acid</td><td rowspan=1 colspan=1>20 mg/dL</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Substance</td><td rowspan=1 colspan=1>Concentration</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2000 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>250 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>40 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>10 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>10 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Nicotine</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Tetracycline</td><td rowspan=1 colspan=1>1.5 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Phenylpropanolamine</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Salicylic acid</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Uric Acid</td><td rowspan=1 colspan=1>20 mg/dL</td></tr><tr><td rowspan=1 colspan=1>DL-β-Hydroxybutyric Acid</td><td rowspan=1 colspan=1>2000 mg/dL</td></tr></table>

# 2. pH Study

To determine if different $\mathsf { p H }$ values in urine would have an effect on the ACCU $\mathrm { N E W S ^ { T M } }$ One Step hCG Pregnancy Test, positive (hCG $2 5 \mathrm { m I U / m L }$ ) and negative urine samples with the following $\mathsf { p H }$ values: 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, and 9.0 were tested. Each urine sample was tested with three test devices from each format of the ACCU NEWSTM One Step hCG Test. Result showed that pH values 2.0-9.0 in urine did not interfere with the performance of the test.

# 3. Specific Gravity

To determine if different specific gravity values in urine can affect the ACCU NEWSTM One Step hCG Pregnancy Test, positive $( 2 5 \mathrm { m I U / m L } )$ and negative hCG urine samples with the following specific gravity levels: 1.003, 1.005, 1.010, 1.015, 1.020, and 1.030 were tested. Each urine sample was tested with three test devices from each format of the ACCU NEWSTM One Step hCG Pregnancy Test. Result showed that the test functioned properly with no interference from these various specific gravity values in urine.

# 4. High Dose/Hook Effect

To determine if high concentrations of hCG would cause false negative result on the ACCU NEWSTM One Step hCG Pregnancy Test. Urine samples spiked with 50, 100, 200, 300, and 500 IU/mL of hCG were tested with the device.

Each urine sample was tested with three test devices from each format of the ACCU NEWSTM One Step hCG Pregnancy Tes. Result showed that the device did not exhibit high dose/hook effect for urine containing up to $5 0 0 \ \mathrm { I U / m L }$ (or $5 0 0 , 0 0 0 \mathrm { m U / m L }$ ) of hCG.

# 5. hCG $\mathbf { \beta }$ -core fragment

To determine the effects of $\beta$ -core hCG fragment on the ACCU NEWSTM One Step hCG Test, the device was tested with negative and positive (hCG 25mIU/mL) hCG urine samples spiked with $\beta$ -core hCG fragment at the concentrations of $2 0 { , } 0 0 0 \ \mathrm { p m o l / L }$ , 25,000 pmol/L, $5 0 { , } 0 0 0 \ \mathrm { p m o l / L }$ , 62,500 pmol/L, 100,000 pmol/L, 125,000 pmol/L, 250,000 pmol/L, 500,000 pmol/L and $1 0 0 0 { , } 0 0 0 \ \mathrm { p m o l / L }$ . Result showed that $\beta$ -core hCG fragments did not interfere with the test result of the device at or below the concentration of 100,000pmol/L. However, at a concentration of ${ > } 1 0 0 , 0 0 0 \ \mathrm { p m o l / L }$ , hCG $\beta$ -core Fragment may cause false negative reading.

H. Clinical performance data a. Clinical Sensitivity: Not Applicable

b. Clinical Specificity: Not Applicable

# c. Other Clinical Supportive Data: OTC lay-user Test Result

Urine samples were randomly collected from 250 female donors at three sites. About $50 \%$ of the donors were suspected to be pregnant. Donor age range was from 18 to 43. Donors were given all three formats of the ACCU NEWSTM One Step hCG Pregnancy Test to test the collected urine samples. The same urine samples were tested by healthcare professionals using the ACCU NEWSTM One Step hCG Pregnancy Test. The recorded test results from the lay users were compared with that from the healthcare professionals.

Table 5: Data Summary of OTC Lay-User Test Result for Strip   
Table 6: Data Summary of OTC Lay-User Test Result for Cassette   

<table><tr><td rowspan=2 colspan=2></td><td rowspan=1 colspan=2>ACCU NEWSTM One Step hCG Pregnancy Test Strip</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=4 colspan=1>ProfessionalTest Result(StripFormat)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>% Agreement</td><td rowspan=1 colspan=2>100%</td></tr></table>

Table 7: Data Summary of OTC Lay-User Test Result for Midstream   

<table><tr><td rowspan=2 colspan=2></td><td rowspan=1 colspan=2>ACCU NEWSTM Step hCG Pregnancy Test Cassette</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=4 colspan=1>ProfessionalTest Result(CassetteFormat)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>% Agreement</td><td rowspan=1 colspan=2>100%</td></tr></table>

<table><tr><td rowspan=2 colspan=2></td><td rowspan=1 colspan=2>ACCU NEWSTM One Step hCG Pregnancy Test Midstream</td></tr><tr><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=4 colspan=1>ProfessionalTest Result(MidstreamFormat)</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>Total</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>126</td></tr><tr><td rowspan=1 colspan=1>% Agreement</td><td rowspan=1 colspan=2>100%</td></tr></table>

Data showed $100 \%$ agreement between lay user results and professional result. This demonstrated that the device was easy enough to be used by untrained lay users. In addition, each participant was given an English questionnaire to assess the readability of the labeling. The result showed that lay users found the product instruction to be easy to understand and the device to be easy to use.

# I. Conclusion

The performance characteristics studies performed demonstrated substantial equivalency between ACCU NEWSTM One Step hCG Pregnancy Test and the predicate device.